- ►nih.gov A Lux, S Maier, S Dinslage, R Süverkrüp, M … - British Journal of Ophthalmology, 2003 - bjo.bmj.com Methods: In a randomised, open label study 22 healthy volunteers applied a
single lyophilisate to one eye (+1 minute) and three conventional eye drops (+1,
16, 31 minutes) of fluorescein ophthalmic solution to the fellow eye. The ... Cited by 10 - Related articles - BL Direct - All 7 versions
R Süverkrüp, S Grunthal, O Krasichkova, S … - European Journal of Pharmaceutics and …, 2004 - Elsevier The ophthalmic lyophilisate carrier system (OLCS) is a novel dosage form for
delivery of pharmacologically active ingredients or other substances improving
the structure of the tear film to the eye. A drop of lyophilisate ... Cited by 6 - Related articles - All 4 versions
- ►bmj.com A Steinfeld, A Lux, S Maier, R Suverkrup, M … - British Medical Journal, 2004 - bjo.bmj.com Methods: Part A: In a randomised study 10 volunteers applied the lyophilisate to
one eye and a conventional fluorescein eye drop to the fellow eye.
Fluorophotometry was performed before and every 2 minutes up to 30 minutes ... Cited by 5 - Related articles - BL Direct - All 9 versions
K Abduljalil, M Diestelhorst, O Doroshyenko, A … - European journal of clinical pharmacology, 2008 - Springer Abstract Objective The objective of this evaluation was to model ocular
pharmacokinetics of fluorescein administered as conventional eye drops and as
lyophilisate to healthy volunteers in order to assess the relative ... Cited by 1 - Related articles - BL Direct - All 4 versions
LI Giannola, V De Caro, G Giandalia, MG … - Journal of Ocular Pharmacology and Therapeutics, 2008 - liebertonline.com Purpose: The model drug norfloxacin (NOR) was encapsulated into trehalose (TRH)
and hydroxyethylcellulose (NAT) microspheres to obtain a novel gelling
ophthalmic delivery sys- tem for prolonged release on corneal tissue. ... Cited by 1 - Related articles - BL Direct - All 3 versions
RT Pijls, HHL Hanssen, R Nuijts, GW Daube, … - Journal of Controlled Release, 2006 - Elsevier Ocular bioavailability of drugs applied via eye drops is very poor. The
absorption of drugs into the eye is severely limited by several protective
mechanisms, for example drainage of the instilled solution, lacrimation and ... Cited by 2 - Related articles - All 2 versions
- ►auckland.ac.nz [PDF] ID Rupenthal, 2008 - researchspace.auckland.ac.nz Page 1. http://researchspace.auckland.ac.nz ResearchSpace@Auckland Copyright
Statement The digital copy of this thesis is protected ... Related articles - View as HTML - All 5 versions
